2021
COVID-19 vaccine acceptance among healthcare workers in the United Arab Emirates
AlKetbi LMB, Elharake JA, Memari SA, Mazrouei SA, Shehhi BA, Malik AA, McFadden SM, Galal B, Yildirim I, Khoshnood K, Omer SB, Memish ZA, AlZarouni AA, AlNeyadi AM, Hosani FA. COVID-19 vaccine acceptance among healthcare workers in the United Arab Emirates. IJID Regions 2021, 1: 20-26. PMID: 35721775, PMCID: PMC8505903, DOI: 10.1016/j.ijregi.2021.08.003.Peer-Reviewed Original ResearchCOVID-19 vaccine acceptanceVaccine acceptanceHealthcare workersCOVID-19 vaccineHCW populationVaccine hesitancyCOVID-19 vaccine informationPublic health messaging campaignsCOVID-19 vaccine concernsCOVID-19 vaccine hesitancyYears of agePhysicians/surgeonsWorld Health OrganizationSimple logistic regressionVaccine informationVaccine concernsGeneral populationPatient decisionHealthcare providersInfection riskLogistic regressionHealthcare authoritiesHealth officialsHealth OrganizationVaccine
2018
2354. Performance of Novel Clinical Case Definitions for Respiratory Syncytial Virus Infections in Young Infants: A Latent Class Analysis
Lalani K, Yildirim I, Phadke V, Bednarczyk R, Omer S. 2354. Performance of Novel Clinical Case Definitions for Respiratory Syncytial Virus Infections in Young Infants: A Latent Class Analysis. Open Forum Infectious Diseases 2018, 5: s700-s701. PMCID: PMC6255342, DOI: 10.1093/ofid/ofy210.2007.Peer-Reviewed Original ResearchRespiratory syncytial virusLaboratory-confirmed RSV infectionAcute respiratory infectionsCase definitionNegative predictive valueWorld Health OrganizationRSV infectionNovel RSV therapeuticsRoutine clinical careLatent class analysisHigh-resource settingsAppropriate case definitionsMonths of ageRSV therapeuticsRespiratory infectionsClinical featuresPediatric morbiditySyncytial virusDisease burdenClinical careChild healthcarePredictive valueYoung infantsMajor causeHealth Organization
2008
Differences in hepatitis A seroprevalence among geographical regions in Turkey: a need for regional vaccination recommendations
Ceyhan M, Yildirim I, Kurt N, Uysal G, Dikici B, Ecevit C, Aydogan A, Koc A, Yasa O, Köseoğlu M, Onal K, Hacimustafaoglu M, Celebi S. Differences in hepatitis A seroprevalence among geographical regions in Turkey: a need for regional vaccination recommendations. Journal Of Viral Hepatitis 2008, 15: 69-72. PMID: 18837839, DOI: 10.1111/j.1365-2893.2008.01034.x.Peer-Reviewed Original ResearchConceptsRecommendation of vaccinationAnti-HAV antibodiesVaccine-preventable infectionsImmunoglobulin G antibodiesYears of ageLow endemicity regionsEnzyme-linked immunosorbentWorld Health OrganizationUniversal hepatitisIntermediate endemicityVaccination recommendationsHepatitis AOverall prevalenceVaccination policyMedical CenterMass vaccinationImmunization policyAge groupsVaccinationHealth OrganizationSocioeconomic differencesHepatitisEndemicityHygiene conditionsAge